-
Mar 28, 2025 | 
linkedin.com | Helen Tang |Scott Pedlar |Lynn Ladd |Nick Hannah |Chris Day |Tony Migliara | +4 more
👋 Welcome, Rafik D. Gabriel! We're excited to announce that Rafik has joined the Paradigm Commercial team, bringing his two decades of banking experience and nearly a decade of specialized commercial real estate lending to our capital markets division. Rafik’s focus will be on capital markets, primarily investment, multi-residential and hospitality acquisitions and listings. With his passion for real estate, robust financial background and commitment to helping clients navigate complex transactions, we know he’ll be an incredible asset to our team and clients. Outside the office, Rafik loves to travel and spend time with his family, two more reasons we think he fits right in. Join us in welcoming Rafik to the Paradigm team! Sarah Vandenbelt Ashley Hopkins #team #newhire #commercialrealestate #ottawa | 86 comments on LinkedIn
-
Jan 23, 2025 | 
herbertsmithfreehills.com | Simon Chapman KC |Kathryn Sanger |Antony Crockett |Helen Tang
The HKIAC has published a new practice note addressing multi-party, multi-contract issues under the 2018 and 2024 HKIAC Administered Arbitration Rules (HKIAC Rules). The practice note primarily addresses the circumstances in which arbitration agreements will (and will not) be deemed "compatible" for the purposes of commencing a single arbitration under multiple contracts or consolidating multiple arbitrations.
-
Jan 14, 2025 | 
herbertsmithfreehills.com | Simon Chapman KC |Kathryn Sanger |Antony Crockett |Helen Tang
The Hong Kong Court of First Instance has granted a worldwide Mareva injunction and related relief in support of an overseas AAA-ICDR arbitration, after "procrastination and obstruction" by one of the respondents in implementing the arbitral tribunal's directions for an escrow arrangement to prevent dissipation of assets (Company A and Another v. Company C [2024] HKCFI 3505).
-
Oct 21, 2024 | 
lexology.com | Simon Chapman KC |Kathryn Sanger |Antony Crockett |Helen Tang |Dana Kim |Murphy Mok | +2 more
The Hong Kong Court of First Instance has stayed proceedings before it and referred a dispute to arbitration 18 months after one of the parties obtained a default judgment on the merits (Tongcheng Travel v. OOO Securities [2024] HKCFI 2710). The court found that the parties had clearly intended to arbitrate the dispute, even though the arbitration agreement did not unambiguously designate an institution and the contract also contained an exclusive jurisdiction clause.
-
Oct 14, 2024 | 
lexology.com | Simon Chapman KC |Kathryn Sanger |Antony Crockett |Helen Tang |Dana Kim |Murphy Mok | +1 more
The Hong Kong Court of First Instance has granted an anti-suit injunction and related relief in favour of a German bank to prevent a sanctioned Russian bank from pursuing Russian court proceedings in breach of an HKIAC arbitration clause (Bank A v. Bank B [2024] HKCFI 2529).
-
Oct 2, 2024 | 
lexology.com | Simon Chapman KC |Kathryn Sanger |Antony Crockett |Helen Tang |Dana Kim |Murphy Mok | +1 more
In a series of recent decisions handed down within days of one another, the Hong Kong courts rejected five attempts by award debtors to set aside, resist enforcement and stay execution of awards rendered against them.
-
Aug 29, 2024 | 
lexology.com | Simon Chapman KC |Kathryn Sanger |Antony Crockett |Helen Tang |Dana Kim |Murphy Mok | +1 more
The Hong Kong Court of First Instance has upheld a challenge to the enforcement of two Shenzhen Court of International Arbitration (SCIA) awards rendered by different tribunals on due process and public policy grounds primarily arising from ex parte communications between the claimant, the tribunal and SCIA (A v. R1 and R2 [2024] HKCFI 1511).
-
Aug 28, 2024 | 
medrxiv.org | Steven P. Wolf |Yanhong Li |Helen Tang |Michael Grant
S.M.T. reports membership on the following American Joint Committee on Cancer: Breast Panel, Neuroendocrine Tumors Committee, and Evidence-Based Medicine Committee. B.D.A. reports membership on the Advisory Board for Letermovir for Merck & Company and being a site principal investigator for Shire and Takeda Pharmaceuticals' for Maribavir Clinical Trial. YesI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
-
Aug 20, 2024 | 
lexology.com | Simon Chapman KC |Kathryn Sanger |Antony Crockett |Helen Tang |Dana Kim |Murphy Mok | +1 more
The Hong Kong Court of First Instance has refused to grant a confidentiality order preventing the public disclosure of information relating to an HKIAC arbitration in parallel litigation proceedings against a related party of the arbitration respondent (Beijing Songxianghu Architectural Decoration Engineering Co., Ltd v. Kitty Kam [2024] HKCFI 1657).
-
Jun 26, 2024 | 
mdpi.com | David Pham |David Phạm |Varsha Sivalingam |Helen Tang |James Montgomery
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
